av/oxford-biomedica--big.svg

COM:OXB

OXB

  • Stock

GBP

Last Close

420.00

25/11 09:17

Market Cap

3.56M

Beta: -

Volume Today

74.18K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
340K
-
1.04M
206.91%
2.06M
97.08%
2.45M
19.33%
2.77M
12.75%
3.79M
37.03%
3.42M
9.93%
4.75M
38.96%
8.22M
73.14%
11.07M
34.77%
12.75M
15.13%
average payables
1.05M
-
2.00M
90.81%
3.19M
59.18%
2.58M
19.00%
2.63M
1.82%
3.71M
41.27%
5.53M
48.86%
7.54M
36.46%
6.52M
13.59%
9.43M
44.70%
9.83M
4.20%
average receivables
3.51M
-
3.51M
0%
35.47M
-
book value per share
0.31
-
0.57
81.59%
0.21
62.85%
0.23
7.13%
0.10
56.28%
0.53
436.86%
1.04
95.18%
1.41
35.58%
2.24
59.12%
0.81
-
capex per share
-0.03
-
-0.14
317.42%
-0.33
135.49%
-0.12
64.26%
-0.03
72.64%
-0.16
389.50%
-0.35
127.71%
-0.17
52.86%
-0.11
32.18%
0.10
-
capex to depreciation
-0.88
-
-5.07
477.87%
-10.27
102.46%
-1.76
82.90%
-0.45
74.39%
-2.33
417.52%
-4.45
91.22%
-1.36
69.52%
-0.76
44.05%
-0.62
18.61%
0.34
155.39%
capex to operating cash flow
0.09
-
0.92
987.28%
1.27
37.82%
1.26
0.74%
-0.66
152.26%
-0.79
19.31%
7.35
1,031.65%
-4.29
158.35%
-0.37
91.33%
1.29
447.56%
-0.34
126.69%
capex to revenue
-0.17
-
-0.41
134.92%
-1.05
156.57%
-0.23
77.87%
-0.05
77.47%
-0.15
190.12%
-0.40
164.76%
-0.15
62.16%
-0.07
56.49%
-0.12
75.70%
0.11
194.33%
cash per share
0.08
-
0.35
358.97%
0.18
48.22%
0.28
51.65%
0.23
16.14%
0.49
113.72%
0.26
47.28%
0.59
125.35%
1.31
122.20%
1.07
-
days of inventory on hand
217.72
-
116.29
46.59%
169.15
45.45%
67.91
59.85%
65.95
2.89%
68.16
3.36%
26.35
61.34%
60.57
129.84%
57.77
4.62%
65.08
12.66%
94.32
44.93%
days payables outstanding
389.97
-
230.36
40.93%
224.29
2.63%
48.60
78.33%
72.87
49.93%
60.07
17.57%
74.70
24.36%
68.15
8.77%
31.91
53.17%
70.13
119.73%
44.35
36.76%
days sales outstanding
68.13
-
54.39
-
debt to assets
0.03
-
0.53
1,676.93%
0.60
14.89%
0.56
6.67%
0.37
35.04%
0.07
81.36%
0.08
10.30%
0.04
47.69%
0.25
530.70%
0.15
38.51%
debt to equity
0.04
-
2.50
5,663.98%
2.73
8.96%
6.00
120.03%
1.18
80.25%
0.11
90.64%
0.12
10.71%
0.05
59.40%
0.56
1,019.92%
0.52
6.76%
dividend yield
earnings yield
-0.34
-
-0.08
75.76%
-0.08
4.61%
-0.15
88.85%
-0.03
79.01%
0.02
152.96%
-0.03
309.43%
-0.01
77.86%
0.02
344.11%
-0.74
-
enterprise value
30.76M
-
92.82M
201.78%
184.96M
99.28%
132.13M
28.57%
314.46M
138.00%
469.92M
49.44%
461.13M
1.87%
790.53M
71.44%
927.25M
17.29%
-27.00M
102.91%
220.16M
915.30%
enterprise value over ebitda
-2.63
-
-9.81
272.95%
-14.88
51.68%
-17.38
16.77%
-88.53
409.50%
38.02
142.95%
-68.90
281.21%
157.79
329.03%
27.77
82.40%
1.11
95.99%
-1.48
232.90%
ev to operating cash flow
-2.79
-
-15.39
451.28%
-14.10
8.37%
-25.88
83.52%
105.56
507.93%
36.52
65.40%
-131.45
459.95%
253.70
293.00%
36.43
85.64%
2.14
94.12%
-7.72
460.66%
ev to sales
5.72
-
6.82
19.11%
11.63
70.58%
4.76
59.09%
8.37
75.86%
7.04
15.88%
7.20
2.29%
9.01
25.18%
6.49
27.94%
-0.19
102.97%
2.46
1,374.67%
free cash flow per share
-0.42
-
-0.29
31.90%
-0.58
101.91%
-0.21
64.14%
0.02
107.84%
0.04
155.78%
-0.40
1,065.18%
-0.13
68.19%
0.19
249.54%
-0.40
-
free cash flow yield
-0.36
-
-0.11
69.84%
-0.18
63.08%
-0.10
42.73%
0.00
103.38%
0.01
70.53%
-0.06
1,158.26%
-0.01
80.08%
0.02
225.23%
-0.18
-
graham net net
-0.08
-
0.10
229.56%
-0.59
675.08%
-0.50
14.70%
-0.61
22.27%
-0.66
8.20%
-0.37
43.98%
-0.26
30.24%
0.77
394.92%
-0.56
-
graham number
1.66
-
1.66
0.30%
1.10
33.76%
1.24
12.55%
0.57
53.89%
1.18
106.50%
2.27
93.08%
1.57
30.77%
3.39
115.37%
5.30
-
income quality
0.86
-
0.56
35.30%
0.93
66.75%
0.45
51.55%
-0.53
216.45%
0.92
275.95%
0.24
73.78%
-0.55
325.68%
1.28
333.98%
0.27
78.57%
0.18
34.01%
intangibles to total assets
0.19
-
0.06
67.72%
0.03
46.04%
0.02
30.52%
0.00
93.65%
0.00
29.82%
0.00
25.76%
0.00
48.64%
0.00
44.77%
0.23
104,872.43%
0.12
46.64%
interest coverage
-3.21K
-
-44.59
98.61%
-4.81
89.20%
-1.25
73.97%
-0.92
26.22%
0.89
196.49%
-1.93
316.18%
-5.29
174.59%
23.39
541.69%
-3.08
113.18%
-16.45
433.61%
interest debt per share
0.00
-
0.03
21,605.54%
0.59
1,815.27%
0.78
33.09%
0.69
11.13%
0.77
10.73%
0.21
73.32%
0.18
10.01%
0.12
33.62%
0.52
-
inventory turnover
1.68
-
3.14
87.21%
2.16
31.25%
5.37
149.08%
5.53
2.98%
5.35
3.25%
13.85
158.68%
6.03
56.49%
6.32
4.84%
5.61
11.23%
3.87
31.00%
invested capital
0.04
-
2.50
5,663.98%
2.73
8.96%
6.00
120.03%
1.18
80.25%
0.11
90.64%
0.12
10.71%
0.05
59.40%
0.56
1,019.92%
203.69M
36,476,015,695.28%
market cap
32.93M
-
106.01M
221.98%
167.06M
57.59%
113.07M
32.32%
291.92M
158.17%
461.01M
57.92%
468.98M
1.73%
823.43M
75.58%
1.03B
24.70%
212.42M
-
net current asset value
2.19M
-
11.99M
446.20%
-15.24M
227.16%
-16.89M
10.76%
-22.27M
31.91%
-8.13M
63.49%
9.64M
218.52%
36.76M
281.41%
113.95M
209.96%
-8.48M
107.45%
-33.18M
291.08%
net debt to ebitda
0.19
-
1.39
651.80%
-1.44
203.25%
-2.51
74.01%
-6.34
153.19%
0.72
111.36%
1.17
62.80%
-6.57
659.58%
-2.98
54.57%
1.11
137.37%
-0.05
104.67%
net income per share
-0.39
-
-0.21
45.26%
-0.25
18.10%
-0.30
18.25%
-0.15
51.37%
0.12
179.43%
-0.22
291.01%
-0.08
64.65%
0.23
391.51%
-1.63
-
operating cash flow per share
-0.39
-
-0.15
61.61%
-0.26
70.86%
-0.09
63.99%
0.05
152.36%
0.20
310.26%
-0.05
124.44%
0.04
180.79%
0.30
682.28%
-0.30
-
payables turnover
0.94
-
1.58
69.29%
1.63
2.71%
7.51
361.45%
5.01
33.30%
6.08
21.32%
4.89
19.59%
5.36
9.62%
11.44
113.52%
5.20
54.49%
8.23
58.13%
receivables turnover
5.36
-
6.71
-
research and ddevelopement to revenue
2.56
-
1.25
51.24%
1.27
2.17%
0.87
31.35%
0.57
34.28%
0.44
22.60%
0.35
20.90%
0.34
3.65%
0.28
17.00%
0.44
54.67%
0.66
52.28%
return on tangible assets
-1.01
-
-0.27
72.89%
-0.26
4.91%
-0.30
15.17%
-0.14
53.86%
0.07
148.64%
-0.13
294.75%
-0.03
74.03%
0.08
335.98%
-0.13
259.02%
-0.71
458.18%
revenue per share
0.19
-
0.34
77.68%
0.31
8.22%
0.50
61.52%
0.61
21.45%
1.02
68.72%
0.88
13.99%
1.10
24.55%
1.71
55.87%
0.93
-
roe
-1.25
-
-0.38
69.85%
-1.20
217.90%
-1.32
10.38%
-1.47
11.22%
0.22
114.80%
-0.21
197.86%
-0.06
73.93%
0.10
283.21%
-0.22
317.44%
-2.13
864.41%
roic
-1.25
-
-0.35
71.74%
-0.28
20.08%
-0.20
30.31%
-0.10
48.77%
0.16
256.97%
-0.10
166.04%
-0.03
68.80%
0.10
395.03%
-0.13
233.52%
-1.60
1,141.97%
sales general and administrative to revenue
0.64
-
0.29
54.36%
0.42
45.82%
0.21
49.39%
0.19
9.75%
0.11
42.49%
0.19
66.62%
0.13
30.78%
0.11
17.34%
0.20
90.00%
0.28
40.78%
shareholders equity per share
0.31
-
0.57
81.59%
0.21
62.85%
0.23
7.13%
0.10
56.28%
0.53
436.86%
1.04
95.18%
1.41
35.58%
2.24
59.12%
0.77
-
stock based compensation to revenue
0.07
-
0.02
75.26%
0.05
184.03%
0.03
32.13%
0.03
19.27%
0.02
25.78%
0.04
87.99%
0.04
6.88%
0.03
25.64%
0.05
65.81%
0.04
15.05%
tangible asset value
6.26M
-
20.93M
234.13%
9.15M
56.28%
11.29M
23.32%
6.05M
46.40%
34.62M
472.39%
75.53M
118.16%
112.67M
49.17%
187.29M
66.22%
130.31M
30.42%
46.85M
64.04%
tangible book value per share
0.22
-
0.52
134.33%
0.18
65.65%
0.20
14.09%
0.10
51.90%
0.53
443.64%
1.04
95.59%
1.41
35.67%
2.24
59.17%
0.49
-
working capital
2.73M
-
13.52M
395.93%
12.54M
7.25%
18.13M
44.50%
15.22M
16.03%
41.02M
169.53%
28.00M
31.75%
55.49M
98.21%
130.54M
135.24%
155.84M
19.38%
97.01M
37.75%

All numbers in GBP (except ratios and percentages)